Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2022

View Archived Issues

Blockade of HIF-1 leads to ROS overproduction in diabetes

MZE-001 shows promising results in murine and canine models of Pompe disease

S-05014, a novel tyrosinase inhibitor with promising anti-Parkinsonian activity

Discovery of novel peptides as probes for crotamine

Ideaya Biosciences presents POLQ inhibitors

U.S. researchers divulge CDK19 inhibitors

Columbia University discloses CD33/CD45 interaction inhibitors

New IRAK and FLT3 inhibitors described by U.S. investigators

Mirati Therapeutics synthesizes new SOS1 inhibitors

New DNA Damage Response Consortium seeks to advance brain cancer research

Microlyse targets VWF and clears microvascular thrombosis

Code Bio and Takeda collaborate on gene therapies for rare diseases

Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases

Phio's INTASYL-based antiviral compounds against SARS-CoV-2 enter in vivo testing

Actinium and AVEO collaborate to develop novel Ac-225 ErbB3-targeted radiotherapy

ALPHA-1062 shown to be neuroprotective in rodent model of traumatic brain injury

JBC-1847 proven effective against Staphylococcus aureus infection

Cantargia reports non-GLP toxicology and pharmacokinetic data on CAN-10

Sorrento's STI-9167 shows neutralizing activity against SARS-CoV-2 Omicron variants

Novel target identified for long QT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...